The RPL35 gene helps cells make ribosomes, the structures that build proteins needed for growth and repair. The protein made by this gene helps your cells keep protein production steady, especially in fast-growing tissues such as the bone marrow. If the gene does not work properly, some people develop Diamond-Blackfan anemia, a condition where the bone marrow makes too few red blood cells, which can cause tiredness, pale skin, and poor growth. Some may also have body differences present from birth.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or directing processes in the body. Some genes carry the code for producing proteins, the parts of cells that do the work. Others mainly regulate when certain processes happen, where they occur, and how strongly they operate. Together, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. You can find more detailed information on this topic in the LearnHub.
Overview
RPL35Gene function
What if the gene works
The RPL35 gene helps build ribosomes, the cell machinery that makes proteins. Its protein forms part of the large ribosome and supports normal cell growth and daily function.
Risk
What if the gene does not work
Variants in the RPL35 gene can cause Diamond-Blackfan anemia, often with low red blood cell production, fatigue, and sometimes birth differences. Effects can range from mild to more severe, which may influence when problems appear and how noticeable they are.
Treatment
What does that mean for your treatment
No treatment or management approach is currently tailored specifically to pathogenic or loss-of-function variants in the RPL35 gene; care is based on the person’s clinical condition rather than the exact RPL35 variant. The RPL35 gene is also being studied in ribosome related conditions and some cancers, but this has not yet changed routine treatment.
Conditions associated with RPL35
Gene function
What if the gene works
Your cells need the RPL35 gene to help make proteins, which support growth, repair, and everyday body functions. It gives instructions for one small ribosome part, and ribosomes are the structures that build proteins. Understanding what the RPL35 gene does helps explain how cells keep routine work running.
The RPL35 gene provides instructions for a protein that becomes part of the ribosome, the cell’s protein-making machine. It joins the larger half of that machine and helps it keep the right shape.
As ribosomes work, the RPL35 protein helps support the step by step use of cellular instructions to assemble proteins. This is central to how your cells make enzymes, structural proteins, and many other working molecules.
By helping cells make proteins smoothly, the RPL35 gene supports growth, repair, and routine upkeep across the body. This includes replacing worn out cell parts and maintaining healthy tissue function.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant can change a gene’s function more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the RPL35 gene can reduce how much RPL35 protein a cell makes or create a shortened, unstable protein that cannot join the ribosome, the cell’s protein making machinery, in the usual way. This is how RPL35 gene variants affect ribosome assembly and lower the cell’s ability to make proteins. Some variants have a milder effect, while more disruptive variants can cause a larger drop in ribosome function and may be linked to earlier or more noticeable Diamond-Blackfan anemia features.
How variants are linked to conditions
Research on how variants in the RPL35 gene are linked to conditions is still developing, and no specific RPL35-related condition has been broadly confirmed across medical genetics. If you have a reported change in the RPL35 gene, your doctor or genetic counselor can explain what that result means in the context of your own health and family history.
A variant is not necessarily a diagnosis
Gene variants are a normal part of human biology and are common throughout the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the RPL35 gene. For many living with an RPL35 change, risk depends more on the specific genetic change and family history than on clear lifestyle factors. Anyone concerned about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of RPL35 variants
How RPL35 gene variants are inherited is usually autosomal dominant. This means a child can inherit the altered RPL35 gene from one parent, and each child of a parent who carries the variant has a 50% chance of inheriting it. Some people with an RPL35-related condition have a new, de novo variant, which means it was not inherited from either parent. When a parent carries the variant, it can be passed to sons and daughters.
What does my RPL35 result mean for my family?
For RPL35, a disease-causing result is most often linked to Diamond-Blackfan anemia, which usually follows a dominant inheritance pattern. That means close relatives, such as a parent, sibling, or child, may also carry the same gene change and could have symptoms ranging from very mild to more noticeable. Some cases happen for the first time in one person, so a parent does not always have the variant.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the RPL35 gene usually uses a blood or saliva sample to read its DNA, often as part of an anemia panel, exome sequencing, or genome sequencing. It can show whether a variant is present and whether it may be inherited or new, but it cannot predict how symptoms will affect someone.
When should I consider getting a genetic test?
Consider RPL35 genetic testing if you or your child has severe anemia starting in infancy, especially with slow growth, birth differences, or a family history of Diamond-Blackfan anemia, an inherited condition that affects red blood cell production. Testing can help confirm whether RPL35 is the cause and clarify whether it may run in the family.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and the specific type of variant. How the body functions over time is shaped by many factors, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines, which is one reason the same treatment may work well for one person but less well for another. Small differences in genes can change how a drug is broken down, moved through the body, or recognized by its target. This is common and can influence how strongly a medicine works or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. By studying links between genes and medications, it helps explain why the same treatment may not work in the same way for everyone. For many drugs, genes can influence both how the body handles the medicine and how strong its effects are. This information can support treatment choices that are better informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the RPL35 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. If you have concerns about how a medicine is working, side effects, or possible interactions, talk with your doctor or pharmacist, especially before starting, stopping, or changing treatment.